Tilray Inc (TLRY)

Add to Watchlists
Create an Alert
45.47 +4.42  +10.77% NASDAQ Jun 19, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All TLRY News

News

View All Events

Events

Date Type Description
08/29/2019 16:30 EDT Misc Tilray Inc Second Quarter Earnings Conference Call in 2019
08/29/2019 Earnings Tilray Inc Second Quarter Earnings in 2019 Release
05/14/2019 17:00 EDT Misc Tilray Inc First Quarter Earnings Conference Call in 2019
05/14/2019 Earnings Tilray Inc First Quarter Earnings in 2019 Release
03/18/2019 17:00 EDT Misc Tilray Inc Fourth Quarter Earnings Conference Call in 2018
03/18/2019 Earnings Tilray Inc Fourth Quarter Earnings in 2018 Release
11/13/2018 16:30 EST Misc Tilray Inc Third Quarter Earnings Conference Call in 2018
11/13/2018 Earnings Tilray Inc Third Quarter Earnings in 2018 Release
08/29/2018 16:30 EDT Misc Tilray Inc Second Quarter Earnings Conference Call in 2018
08/29/2018 Earnings Tilray Inc Second Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 58.36M
Total Expenses (TTM) 135.72M
Net Income (TTM) -92.84M

Balance Sheet View Statement

Total Assets (Quarterly) 1.077B
Total Liabilities (Quarterly) 694.68M
Shareholders Equity (Quarterly) 381.92M

Cash Flow Statement View Statement

Cash from Operations (TTM) -69.36M
Cash from Investing (TTM) -225.33M
Cash from Financing (TTM) 577.83M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.tilray.com
  • Investor Relations URL: N/A
  • HQ State/Province: British Columbia
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: N/A
  • Next Earnings Release: Aug. 29, 2019
  • Last Earnings Release: May. 14, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Tilray Inc is engaged in the sale and development of medical cannabis. Geographically, the company derives the majority of its revenue from Canada. The product categories of the company include dried cannabis which includes whole flower and ground flower, and cannabis extract which include full spectrum and purified oil drops and capsules.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 45.47
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
MJ ETFMG Alternative Harvest ETF 7.20%
HMMJ.TO Horizons Marijuana Life Sciences ETF 6.71%
SEED.TO Evolve Marijuana ETF 3.97%
ZVGIX Zevenbergen Genea Institutional 3.90%
SAGAX Virtus Zevenbergen Innovative Gr Stk A 3.65%
YOLO AdvisorShares Pure Cannabis ETF 2.97%
ZVNBX Zevenbergen Growth Investor 2.39%
RAM2420 Purpose Marijuana Opportunities Cl F 1.21%
MJJ.NO Purpose Marijuana Opportunities ETF 1.21%

Comparables

Edit
A Agilent Technologies Inc
NVS Novartis AG
FVPI FV Pharma International Corp
WUHN Wuhan General Group (China) Inc
MDLH Medical International Technology Inc

Excel Add-In Codes

  • Name: =YCI("TLRY","name")
  • Description: =YCI("TLRY","description")
  • Sector: =YCI("TLRY","sector")
  • Industry: =YCI("TLRY","industry")
  • Est. Current Fiscal Year End: =YCI("TLRY","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.